Insider trade

Director reported a non-open-market transaction in CORT

Traded Dec 12, 2025 · Filed Dec 17, 2025

Corcept TherapeuticsCORT

200K
Shares

Why it stands out

Not classified as an open-market trade.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 12, 2025
Reporting period: Not applicable
Filed with the SEC: Dec 17, 2025

DirectorIndirect holdingOther

Context

Classification

other

Code J — not an open-market trade

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-25-321408

Filed / recorded

Dec 17, 2025, 7:00 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

James N Wilson

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Dec 12, 2025

Transaction code

J

Shares / units

200,000

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

200,000

Ownership form

Indirect — James N. Wilson 2025 Grantor Retained Annuity Trust.

Amendment

No

Footnotes from the filing

Transfer of shares without consideration to James N. Wilson 2025 Grantor Retained Annuity Trust.
On December 12, 2025, the Reporting Person contributed 200,000 shares to a grantor retained annuity trust for the benefit of himself, Pamela D. Wilson and his two children.